CTAC NV (CTAC.AS) Stock Fundamental Analysis

AMS:CTAC • NL0000345577

3.03 EUR
-0.02 (-0.66%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

5

CTAC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 75 industry peers in the IT Services industry. CTAC has only an average score on both its financial health and profitability. CTAC scores decently on growth, while it is valued quite cheap. This could make an interesting combination. CTAC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year CTAC was profitable.
  • CTAC had a positive operating cash flow in the past year.
  • CTAC had positive earnings in each of the past 5 years.
  • In the past 5 years CTAC always reported a positive cash flow from operatings.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

  • CTAC's Return On Assets of 8.07% is amongst the best of the industry. CTAC outperforms 81.54% of its industry peers.
  • CTAC's Return On Equity of 18.74% is fine compared to the rest of the industry. CTAC outperforms 78.46% of its industry peers.
  • CTAC has a Return On Invested Capital (6.80%) which is in line with its industry peers.
  • CTAC had an Average Return On Invested Capital over the past 3 years of 7.72%. This is below the industry average of 11.55%.
Industry RankSector Rank
ROA 8.07%
ROE 18.74%
ROIC 6.8%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.59%
ROE(5y)12.47%
ROIC(3y)7.72%
ROIC(5y)7.7%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • CTAC has a Profit Margin (3.10%) which is comparable to the rest of the industry.
  • CTAC's Profit Margin has improved in the last couple of years.
  • CTAC has a worse Operating Margin (2.97%) than 67.69% of its industry peers.
  • In the last couple of years the Operating Margin of CTAC has grown nicely.
  • CTAC's Gross Margin of 37.21% is on the low side compared to the rest of the industry. CTAC is outperformed by 66.15% of its industry peers.
  • CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
OM growth 3Y-9.69%
OM growth 5Y12.15%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

  • CTAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CTAC has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CTAC has been increased compared to 5 years ago.
  • Compared to 1 year ago, CTAC has an improved debt to assets ratio.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CTAC has an Altman-Z score of 3.79. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CTAC (3.79) is better than 81.54% of its industry peers.
  • A Debt/Equity ratio of 0.36 indicates that CTAC is not too dependend on debt financing.
  • CTAC has a better Debt to Equity ratio (0.36) than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 3.79
ROIC/WACC1.05
WACC6.47%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.00. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAC has a worse Current ratio (1.00) than 64.62% of its industry peers.
  • CTAC has a Quick Ratio of 1.00. This is a bad value and indicates that CTAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CTAC's Quick ratio of 1.00 is on the low side compared to the rest of the industry. CTAC is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 300.00% over the past year.
  • CTAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.53% yearly.
  • CTAC shows a decrease in Revenue. In the last year, the revenue decreased by -2.28%.
  • The Revenue has been growing by 8.74% on average over the past years. This is quite good.
EPS 1Y (TTM)300%
EPS 3Y-5.09%
EPS 5Y24.53%
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%

3.2 Future

  • CTAC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.55% yearly.
  • CTAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.82 indicates a reasonable valuation of CTAC.
  • Compared to the rest of the industry, the Price/Earnings ratio of CTAC indicates a rather cheap valuation: CTAC is cheaper than 86.15% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of CTAC to the average of the S&P500 Index (27.07), we can say CTAC is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 7.07, the valuation of CTAC can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CTAC is valued cheaply inside the industry as 90.77% of the companies are valued more expensively.
  • CTAC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.05.
Industry RankSector Rank
PE 10.82
Fwd PE 7.07
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CTAC is valued cheaper than 86.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.44
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CTAC's earnings are expected to grow with 21.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)0.44
EPS Next 2Y30.93%
EPS Next 3Y21.55%

7

5. Dividend

5.1 Amount

  • CTAC has a Yearly Dividend Yield of 3.61%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.39, CTAC pays a bit more dividend than its industry peers.
  • CTAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.61%

5.2 History

  • On average, the dividend of CTAC grows each year by 17.42%, which is quite nice.
Dividend Growth(5Y)17.42%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 26.85% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
  • CTAC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP26.85%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (2/27/2026, 7:00:00 PM)

3.03

-0.02 (-0.66%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners6.76%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap42.87M
Revenue(TTM)188.22M
Net Income(TTM)5.81M
Analysts80
Price Target2.87 (-5.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.61%
Yearly Dividend0.11
Dividend Growth(5Y)17.42%
DP26.85%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.44%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.51%
Revenue NY rev (3m)-4.51%
Valuation
Industry RankSector Rank
PE 10.82
Fwd PE 7.07
P/S 0.23
P/FCF N/A
P/OCF 20.81
P/B 1.38
P/tB 8.57
EV/EBITDA 4.44
EPS(TTM)0.28
EY9.24%
EPS(NY)0.43
Fwd EY14.14%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.15
OCFY4.8%
SpS13.23
BVpS2.19
TBVpS0.35
PEG (NY)0.23
PEG (5Y)0.44
Graham Number3.72
Profitability
Industry RankSector Rank
ROA 8.07%
ROE 18.74%
ROCE 14.63%
ROIC 6.8%
ROICexc 7.19%
ROICexgc 19.37%
OM 2.97%
PM (TTM) 3.1%
GM 37.21%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.59%
ROE(5y)12.47%
ROIC(3y)7.72%
ROIC(5y)7.7%
ROICexc(3y)9.79%
ROICexc(5y)10.06%
ROICexgc(3y)82.95%
ROICexgc(5y)110.67%
ROCE(3y)14.7%
ROCE(5y)14.69%
ROICexgc growth 3Y-17.16%
ROICexgc growth 5Y33.25%
ROICexc growth 3Y-3.08%
ROICexc growth 5Y14.74%
OM growth 3Y-9.69%
OM growth 5Y12.15%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score6
Asset Turnover2.6
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 1.03
Cap/Depr 69.59%
Cap/Sales 1.99%
Interest Coverage 14.26
Cash Conversion 18.86%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 3.79
F-Score6
WACC6.47%
ROIC/WACC1.05
Cap/Depr(3y)40.77%
Cap/Depr(5y)30.88%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)410.26%
Profit Quality(5y)379.1%
High Growth Momentum
Growth
EPS 1Y (TTM)300%
EPS 3Y-5.09%
EPS 5Y24.53%
EPS Q2Q%N/A
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.28%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%3.33%
Revenue Next Year2.42%
Revenue Next 2Y3.37%
Revenue Next 3Y3.63%
Revenue Next 5Y7.12%
EBIT growth 1Y12.1%
EBIT growth 3Y-4.89%
EBIT growth 5Y21.95%
EBIT Next Year46.67%
EBIT Next 3Y16.96%
EBIT Next 5YN/A
FCF growth 1Y-117.59%
FCF growth 3Y-8.31%
FCF growth 5Y-0.45%
OCF growth 1Y-82.03%
OCF growth 3Y1.58%
OCF growth 5Y4.33%

CTAC NV / CTAC.AS FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 7 / 10 to CTAC NV (CTAC.AS). This can be considered as Undervalued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


What is the financial health of CTAC NV (CTAC.AS) stock?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


Can you provide the dividend sustainability for CTAC stock?

The dividend rating of CTAC NV (CTAC.AS) is 7 / 10 and the dividend payout ratio is 26.85%.